The Consortium for Canine Comparative Oncology (c3o), a collaboration between Duke Cancer Institute and North Carolina State University College of Veterinary Medicine, will host its Fourth Annual Canine Comparative Oncology Symposium on Friday, Feb. 15, from 7:30 a.m. to 5 p.m. at the Durham Convention Center in Durham, North Carolina.
Duke and NC State joined forces in 2015 to explore new cancer therapies offering better efficacy and less toxicity for both humans and canines. Researchers at both institutions are studying naturally occurring cancers in humans and canines. This collaboration allows investigators to leverage research and resources to benefit both species, ensuring better treatments and outcomes.
This year's consortium features Elizabeth McNiel, DVM, PhD, DACVIM (Onc), DACVR(RO), principal research scientist for Companion Animal Research and Translational and Comparative Medical Research at Elanco Animal Health, an Indiana-based animal health company that develops products and knowledge services to prevent and treat disease in food, animals and pets.
The symposium will feature presentations by 2018 C3O Pilot Project Awardees, a poster session highlighting current cancer-relevant research being done at both institutions and several presentations, including a keynote address by Elizabeth McNiel, DVM, PhD, DACVIM(Onc), DACVR(RO) from Elanco Animal Health. Details about a joint RFA for pilot projects in canine comparative oncology (to be released in spring 2019) will also be shared at the symposium.
Abstracts, for consideration to present during the poster session, will be accepted through Friday, January 4. Abstracts will be reviewed by the C3O Steering Committee and the top four submissions will be selected to give an oral presentation at the symposium.
To register, and to submit an abstract, please visit: Registration. Registration for the symposium is open through Friday, Jan. 25, 2019.
Additional information about this collaboration and the symposium can be found at C3Oncology.org.